Contineum Therapeutics, Inc. reported its financial results for Q1 2026 on May 5, 2026, detailing its operational performance as of March 31, 2026. The filing is categorized as 'Quarterly Earnings Reports' and the sentiment is neutral; it is a significant event for the company.